Literature DB >> 32519936

Occurrence of ESBL-Producing Escherichia coli ST131, Including the H30-Rx and C1-M27 Subclones, Among Urban Seagulls from the United Kingdom.

Flavia Zendri1, Iuliana E Maciuca1, Simon Moon2, Philip H Jones3, Andy Wattret1, Richard Jenkins4, Andy Baxter5, Dorina Timofte1.   

Abstract

Antimicrobial resistance is a public health concern. Understanding any role that urban seagulls may have as a reservoir of resistant bacteria could be important for reducing transmission. This study investigated fecal Escherichia coli isolates from seagulls (herring gulls and lesser black-backed gulls) to determine the prevalence of extended-spectrum cephalosporin-resistant (ESC-R) and fluoroquinolone-resistant E. coli among gull species from two cities (Taunton and Birmingham) in the United Kingdom (UK). We characterized the genetic background and carriage of plasmid-mediated resistance genes in extended-spectrum β-lactamase (ESBL)-producing E. coli obtained from these birds. Sixty ESC-R E. coli isolates were obtained from 39 seagulls (39/78, 50%), of which 28 (28/60, 46.7%) were positive for plasmid-mediated CTX-M and/or AmpC β-lactamase resistance genes. Among these, blaCTX-M-15, blaCTX-M-14, and blaCMY-2 predominated. Three isolates belonging to the B2-ST131 clone were detected, of which two harbored blaCTX-M-15 (typed to C2/H30Rx) and one harbored blaCTX-M-27 and was typed to C1/H30-R (recently described as the C1-M27 sublineage). The plasmid-mediated quinolone resistance (PMQR) gene carriage prevalence (11.7%) consisted of aac(6')-Ib-cr and qnrB genes. No carbapenem or colistin resistance genes were detected. Urban seagulls in the UK are colonized and can spread major antimicrobial-resistant E. coli isolates harboring ESBL and PMQR determinants, including clinically important strains such as the pandemic clone B2-ST131 and the C1-M27 subclade. This is the first report of ST131-C1-M27 subclade in wildlife in the UK and in seagulls worldwide.

Entities:  

Keywords:  AmpC; B2-ST131; C1-M27; ESBLs; Escherichia coli; Larus spp; PMQR

Mesh:

Substances:

Year:  2019        PMID: 32519936     DOI: 10.1089/mdr.2019.0351

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  5 in total

1.  ESBL/pAmpC-Producing Escherichia coli Causing Urinary Tract Infections in Non-Related Companion Animals and Humans.

Authors:  Adriana Belas; Cátia Marques; Juliana Menezes; Luís Telo da Gama; Patrícia Cavaco-Silva; Constança Pomba
Journal:  Antibiotics (Basel)       Date:  2022-04-22

2.  Wide Spread of bla CTX-M-9/mcr-9 IncHI2/ST1 Plasmids and CTX-M-9-Producing Escherichia coli and Enterobacter cloacae in Rescued Wild Animals.

Authors:  Marisa Haenni; Véronique Métayer; Romane Jarry; Antoine Drapeau; Marie-Pierre Puech; Jean-Yves Madec; Nicolas Keck
Journal:  Front Microbiol       Date:  2020-11-17       Impact factor: 5.640

3.  Genomic comparisons of Escherichia coli ST131 from Australia.

Authors:  Dmitriy Li; Ethan R Wyrsch; Paarthiphan Elankumaran; Monika Dolejska; Marc S Marenda; Glenn F Browning; Rhys N Bushell; Jessica McKinnon; Piklu Roy Chowdhury; Nola Hitchick; Natalie Miller; Erica Donner; Barbara Drigo; Dave Baker; Ian G Charles; Timothy Kudinha; Veronica M Jarocki; Steven Philip Djordjevic
Journal:  Microb Genom       Date:  2021-12

4.  Comparison of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates From Rooks (Corvus frugilegus) and Contemporary Human-Derived Strains: A One Health Perspective.

Authors:  Bálint József Nagy; Bence Balázs; Isma Benmazouz; Péter Gyüre; László Kövér; Eszter Kaszab; Krisztina Bali; Ádám Lovas-Kiss; Ivelina Damjanova; László Majoros; Ákos Tóth; Krisztián Bányai; Gábor Kardos
Journal:  Front Microbiol       Date:  2022-01-13       Impact factor: 5.640

5.  Wild Boars as an Indicator of Environmental Spread of ESβL-Producing Escherichia coli.

Authors:  Alessandra Mercato; Claudia Cortimiglia; Aseel Abualsha'ar; Aurora Piazza; Federica Marchesini; Giovanni Milani; Silvia Bonardi; Pier Sandro Cocconcelli; Roberta Migliavacca
Journal:  Front Microbiol       Date:  2022-04-01       Impact factor: 6.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.